Ignite Creation Date:
2025-12-25 @ 3:17 AM
Ignite Modification Date:
2026-01-09 @ 10:48 PM
Study NCT ID:
NCT01307605
Status:
TERMINATED
Last Update Posted:
2023-06-27
First Post:
2011-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular Lymphoma
Sponsor:
Swiss Cancer Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | contiguous stage II grade 1 follicular lymphoma | View |
| None | contiguous stage II grade 2 follicular lymphoma | View |
| None | contiguous stage II grade 3 follicular lymphoma | View |
| None | noncontiguous stage II grade 1 follicular lymphoma | View |
| None | noncontiguous stage II grade 2 follicular lymphoma | View |
| None | noncontiguous stage II grade 3 follicular lymphoma | View |
| None | stage III grade 1 follicular lymphoma | View |
| None | stage III grade 2 follicular lymphoma | View |
| None | stage III grade 3 follicular lymphoma | View |
| None | stage IV grade 1 follicular lymphoma | View |
| None | stage IV grade 2 follicular lymphoma | View |
| None | stage IV grade 3 follicular lymphoma | View |